Establishment of a novel therapeutic vector targeting the trigeminal ganglion in rats

References

• LinTGongLSunXHEffectiveness and safety of 0.5% ganciclovir in situ ophthalmic gel for herpes simplex keratitis, a multicenter, randomized, investigator-masked, parallel group study in Chinese patientsDrug Des Devel Ther20137361368
   PubMed Web of Science ®Google Scholar
• ChenDZhangDXuLThe alterations of matrix metalloproteinase-9 in mouse brainstem during herpes simplex virus type 1-induced facial palsyJ Mol Neurosci201351370370923817985
   PubMed Web of Science ®Google Scholar
• AlekseevODonovanKZaizkhan-CliffordJInhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitisInvest Ophthalmol Vis Sci201455270671524370835
   PubMed Web of Science ®Google Scholar
• MesserHGJacobsDDhummakuptAInhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neuronsJ Virol20158963417342025552720
   PubMed Web of Science ®Google Scholar
• SheppardJDWertheimerMLScoperSVModalities to decrease stromal herpes simplex keratitis reactivation ratesArch Ophthalmol2009127785285619597103
   PubMedGoogle Scholar
• ArefianEBamdadTSoleimanjahiHA kinetic study of gamma interferon production in herpes simplex virus-1 DNA prime-protein boost regimen comparing to DNA or subunit vaccinationMol Biol (Mosk)2009433388393
   Web of Science ®Google Scholar
• HuKDouJYuFAn ocular mucosal administration of nanoparticles containing DNA vaccine Prsc-Gd-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in miceVaccine20112971455146221185849
   PubMed Web of Science ®Google Scholar
• TheopoldCPGheerardynRBleizifferOA novel replication-defective HSV-1 vector for regulatable gene delivery to woundsJ Am Coll Surg200419935758
   Web of Science ®Google Scholar
• PalmerJABranstonRHLilleyCEDevelopment and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous systemJ Virol2000745604561810823868
   PubMed Web of Science ®Google Scholar
• AnestiAMPeetersPJRoyauxIEfficient delivery of RNA interference to peripheral neurons in vivo using herpes simplex virusNucleic Acids Res20083614e8618583367
   PubMed Web of Science ®Google Scholar
• XuKLiuXNZhangHBReplication-defective HSV-1 effectively targets targets trigeminal ganglion and inhibits viral pathopoiesis by mediating interferon gamma expression in SH-SY5Y cellsJ Mol Neurosci2014531788624347277
   PubMed Web of Science ®Google Scholar
• XuKWangXShiQHuman prion protein mutants with deleted and inserted octarepeats undergo different pathways to trigger cell apoptosisJ Mol Neurosci201143322523420526696
   PubMed Web of Science ®Google Scholar
• ChiangLCChiangWChangMYAntiviral activity of Plantago major extracts and related compounds in vitroAntiviral Res2002551536212076751
   PubMed Web of Science ®Google Scholar
• WangXShiQXuKFamilial CJD associated PrP mutants within transmembrane region induced Ctm-PrP retention in ER and triggered apoptosis by ER stress in SH-SY5Y cellsPLoS One201161e1460221298055
   PubMed Web of Science ®Google Scholar
• Shahidi BonjarMRShahidi BonjarLDesign of a new therapy for patients with chronic kidney disease: use of microarrays for selective hemoadsorption of uremic wastes and toxins to improve homeostasisDrug Des Devel Ther20159625629
   PubMed Web of Science ®Google Scholar
• WhiteheadJLOharaPTTauscherANA procedure to deliver simplex virus to the murine trigeminal ganglionBrain Res Brain Res Protoc2003121606612928046
   PubMedGoogle Scholar
• MeunierALatremoliereAMauborgneAAttenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neuronsMol Ther201511460861615771963
   PubMedGoogle Scholar
• GoinsWFCohenJBGloriosoJCGene therapy for the treatment of chronic peripheral nervous system painNeurobiol Dis201248225527022668775
   PubMed Web of Science ®Google Scholar
• FarooqAVShuklaDHerpes simplex epithelial and stromal keratitis: an epidemiologic updateSurv Ophthalmol201257544846222542912
   PubMed Web of Science ®Google Scholar
• vanVelzenMvan LoenenFBMeestersRJLatent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individualsJ Infect Dis2012205101539154322457282
   PubMed Web of Science ®Google Scholar
• BieberTChosidowOBodsworthNEfficacy and safety of acyclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes: a double-blind placebo-controlled, self-initiated trialJ Drugs Dermatol201413779179825007361
   PubMed Web of Science ®Google Scholar
• ColinJPrisantOCochenerBComparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicusOphthalmology200010781507151110919899
   PubMed Web of Science ®Google Scholar
• TurnerLDBeckingsalePAcyclovir-resistant herpetic keratitis in a solid-organ transplant recipient on systemic immunosuppressionClin Ophthalmol2013722923223386782
   PubMedGoogle Scholar
• SiaKCWangGYHoIAOptimal purification method for herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administrationJ Virol Methods2007139216617417074404
   PubMed Web of Science ®Google Scholar
• MoriuchiSKriskyDMMarconiPCHSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcomaGene Ther20007171483149011001368
   PubMed Web of Science ®Google Scholar
• GoelNRongQZimmermanDALEAPS heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protectionVaccine20032127–304410442014505924
   PubMed Web of Science ®Google Scholar
• QuenelleDCCollinsDJRiceTLEffect of an immune enhancer, GPI-100, on vaccination with live attenuated herpes simplex virus type 2 or glycoprotein D on genital HSV-2 infections of guinea pigsAntiviral Res200880222322418573279
   PubMed Web of Science ®Google Scholar
• FeketeTPazmandiKSzaboAThe antiviral immune response in human conventional dendritic cells is controlled by the mammalian target of rapamycinJ Leukoc Biol201496457958925001862
   PubMed Web of Science ®Google Scholar
• WangLCChengSOChangSPEnterovirus 71 proteins 2A and 3D antagonize the antiviral activity of gamma interferon via signaling attenuationJ Virol201589147028703725926657
   PubMed Web of Science ®Google Scholar